Enzo BiochemENZB

13F holders, Q1 2025 (March 31)
41holders −3
3new positions
6sold out
2famous investors
$0.37avg. 13F price*

At the end of Q1 2025, 41 institutions reported holding Enzo Biochem Inc. (ENZB) in their 13F filings, down 3 from Q4 2024. 3 opened new positions and 6 sold out. The largest holders were Harbert Fund Advisors, LLC ($1.9M), Renaissance Technologies ($770K) and Vanguard Group Inc. ($688K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Enzo Biochem Inc.
CUSIP
294100102
Latest filing quarter
Q2 2025

History

Number of 13F holders

01020304050 Q1 2024: 41Q1 2024Q2 2024: 39Q2 2024Q3 2024: 43Q3 2024Q4 2024: 44Q4 2024Q1 2025: 41Q1 2025Q2 2025: 7Q2 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions3$15K
Exits6$94K

All 13F filers, Q4 2024 → Q1 2025: 532,646 shares bought and 716,418 shares sold, net −183,772 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

Harbert Fund Advisors, LLC 2.22% No change 5,175,913 $1.9M
Renaissance Technologies 0.00% Reduce -12.1% 2,082,229 $770K
Vanguard Group Inc. 0.00% No change 1,859,002 $688K
BlackRock, Inc. 0.00% Reduce -0.2% 957,775 $354K
Mink Brook Asset Management LLC 0.31% No change 807,899 $299K
Geode Capital Management, LLC 0.00% Add +17.4% 431,042 $160K
Wittenberg Investment Management, Inc. 0.05% Add +46.2% 274,095 $101K
RBF Capital, LLC 0.01% No change 250,359 $93K
Citadel Advisors 0.00% Add +358.9% 210,877 $78K
State Street Corp. 0.00% No change 168,881 $62K
Lepercq De Neuflize Asset Management LLC 0.06% Add +27.1% 156,303 $58K
Dimensional Fund Advisors LP 0.00% Reduce -53.3% 138,126 $51K
Squarepoint Ops LLC 0.00% Add +92.5% 127,440 $47K
BBR Partners, LLC 0.00% No change 100,000 $37K
Nierenberg Investment Management Company, LLC 0.02% No change 88,555 $33K
Bridgeway Capital Management, LLC 0.00% Reduce -56.4% 77,200 $29K
Morgan Stanley 0.00% No change 67,342 $25K
Northern Trust Corp. 0.00% No change 67,204 $25K
Susquehanna International Group, LLP 0.00% Add +77.5% 60,041 $22K
Lazard Asset Management LLC 0.00% No change 50,453 $18K
T. Rowe Price Associates Inc. 0.00% No change 44,800 $17K
UBS Group AG 0.00% Add +16343.5% 45,713 $17K
Kempner Capital Management Inc. 0.01% No change 25,475 $9K
XTX Topco Ltd 0.00% Add +33.2% 21,193 $8K
Two Sigma Securities, LLC 0.00% New 19,746 $7K
Trivium Point Advisory, LLC 0.00% No change 19,500 $7K
Baader Bank Aktiengesellschaft 0.00% New 22,678 $7K
Raymond James Financial Inc. 0.00% No change 17,016 $6K
Shulman DeMeo Asset Management LLC 0.00% No change 15,487 $6K
Virtu Financial LLC 0.00% Reduce -75.3% 11,920 $4K
Tower Research Capital LLC (TRC) 0.00% Reduce -22.4% 10,026 $3K
Bank of America Corp. 0.00% Add +78.9% 3,962 $1K
Medallion Wealth Advisors, LLC 0.00% No change 2,800 $1K
JPMorgan Chase & Co. 0.00% Reduce -0.4% 1,915 $708
Fort Vancouver Investment Management, LLC 0.00% New 1,599 $592
Wells Fargo & Company 0.00% No change 793 $294
PNC Financial Services Group, Inc. 0.00% No change 700 $259
FMR LLC 0.00% Reduce -22.7% 429 $159
Sound Income Strategies, LLC 0.00% No change 10 $4
Royal Bank of Canada 0.00% No change 1,000 $0
Simplex Trading, LLC 0.00% Reduce -99.3% 2 $0

"% of holder's portfolio" is ENZB's weight in each manager's 13F, not the share of Enzo Biochem Inc. the manager owns.